Tag Archives: Commission

Europe: Resisting the Anticompetitive Crusade

It’s been another rocky few weeks for pharma in Europe. Particularly for big brand name companies. But necessity is proving the mother of invention, says Pharm Exec’s Brussels correspondent, Reflector. AstraZeneca suffered a serious setback at the start of July when the European General Court ruled that it had illegally prevented generic competition. The case […]
Posted in Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta